GB9717428D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB9717428D0
GB9717428D0 GBGB9717428.8A GB9717428A GB9717428D0 GB 9717428 D0 GB9717428 D0 GB 9717428D0 GB 9717428 A GB9717428 A GB 9717428A GB 9717428 D0 GB9717428 D0 GB 9717428D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9717428.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9717428.8A priority Critical patent/GB9717428D0/en
Publication of GB9717428D0 publication Critical patent/GB9717428D0/en
Priority to MA25211A priority patent/MA26531A1/en
Priority to PE1998000735A priority patent/PE105699A1/en
Priority to ARP980104050A priority patent/AR016629A1/en
Priority to AU93430/98A priority patent/AU9343098A/en
Priority to JP51280899A priority patent/JP2002511101A/en
Priority to EP98946351A priority patent/EP1007010A2/en
Priority to PCT/EP1998/005194 priority patent/WO1999008666A2/en
Priority to ZA9807392A priority patent/ZA987392B/en
Priority to TR1999/03209T priority patent/TR199903209T2/en
Priority to CA002295016A priority patent/CA2295016A1/en
Priority to BR9810458-6A priority patent/BR9810458A/en
Priority to KR19997012116A priority patent/KR20010014080A/en
Priority to CN98806380A priority patent/CN1263461A/en
Priority to CO98047010A priority patent/CO4960657A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
GBGB9717428.8A 1997-08-19 1997-08-19 Pharmaceutical composition Pending GB9717428D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB9717428.8A GB9717428D0 (en) 1997-08-19 1997-08-19 Pharmaceutical composition
MA25211A MA26531A1 (en) 1997-08-19 1998-08-12 PHARMACEUTICAL COMPOSITION
PE1998000735A PE105699A1 (en) 1997-08-19 1998-08-14 PHARMACEUTICAL COMPOSITION
ARP980104050A AR016629A1 (en) 1997-08-19 1998-08-14 A SOLUTION THAT INCLUDES A PHARMACEUTICALLY ACTIVE AZAESTEROID AND A GLICEROL FATTY ACID ESTER OR PROPILES GLICOL, PHARMACEUTICAL COMPOSITIONS THAT COMPLETE THE GELATINE SOLUTION AND CAPSULES FILLED WITH THE PHARMACEUTICAL COMPOSITION.
CN98806380A CN1263461A (en) 1997-08-19 1998-08-17 Pharmaceutical composition
EP98946351A EP1007010A2 (en) 1997-08-19 1998-08-17 Pharmaceutical composition comprising an azasteroid
JP51280899A JP2002511101A (en) 1997-08-19 1998-08-17 Pharmaceutical composition
AU93430/98A AU9343098A (en) 1997-08-19 1998-08-17 Pharmaceutical composition
PCT/EP1998/005194 WO1999008666A2 (en) 1997-08-19 1998-08-17 Pharmaceutical composition comprising an azateroid
ZA9807392A ZA987392B (en) 1997-08-19 1998-08-17 Pharmaceutical composition.
TR1999/03209T TR199903209T2 (en) 1997-08-19 1998-08-17 Pharmaceutical composition.
CA002295016A CA2295016A1 (en) 1997-08-19 1998-08-17 Pharmaceutical composition
BR9810458-6A BR9810458A (en) 1997-08-19 1998-08-17 Solution, pharmaceutical composition, and liquid charged gelatin capsule
KR19997012116A KR20010014080A (en) 1997-08-19 1998-08-17 Pharmaceutical composition
CO98047010A CO4960657A1 (en) 1997-08-19 1998-08-18 PHARMACEUTICAL COMPOSITION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9717428.8A GB9717428D0 (en) 1997-08-19 1997-08-19 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB9717428D0 true GB9717428D0 (en) 1997-10-22

Family

ID=10817619

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9717428.8A Pending GB9717428D0 (en) 1997-08-19 1997-08-19 Pharmaceutical composition

Country Status (15)

Country Link
EP (1) EP1007010A2 (en)
JP (1) JP2002511101A (en)
KR (1) KR20010014080A (en)
CN (1) CN1263461A (en)
AR (1) AR016629A1 (en)
AU (1) AU9343098A (en)
BR (1) BR9810458A (en)
CA (1) CA2295016A1 (en)
CO (1) CO4960657A1 (en)
GB (1) GB9717428D0 (en)
MA (1) MA26531A1 (en)
PE (1) PE105699A1 (en)
TR (1) TR199903209T2 (en)
WO (1) WO1999008666A2 (en)
ZA (1) ZA987392B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6633A (en) * 2002-11-22 2004-05-23 Omega Farma Ehf. Compositions of finasteride tablets
AU2004264958B2 (en) 2003-08-13 2010-04-15 Biocon, Ltd Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
EP1704162A1 (en) * 2004-01-02 2006-09-27 PharmaCon Forschung und Beratung GmbH Method for producing 1,2-unsaturated azasteroids
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
US9011908B2 (en) 2009-04-06 2015-04-21 Banner Life Sciences Llc Progesterone solutions for increased bioavailability
ES2385240B1 (en) 2010-07-26 2013-09-23 Gp-Pharm, S.A. CAPSULES OF ACTIVE PHARMACEUTICAL PRINCIPLES AND POLYINSATURATED FATTY ACIDS FOR THE TREATMENT OF PROSTATE DISEASES.
US8900631B2 (en) 2011-04-28 2014-12-02 Health Science Funding, LLC Dosage form to increase prasterone bioavailability
CN103169712B (en) * 2011-12-20 2017-10-27 重庆华邦制药有限公司 Improve dutasteride's preparation of bioavilability and preparation method thereof
WO2014002015A1 (en) 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
EP2949319A1 (en) 2014-05-26 2015-12-02 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
KR101679992B1 (en) 2015-12-31 2016-11-28 주식회사 유유제약 Pharmaceutical composition comprising dutasteride and propylene glycol monolaurate and preparation method of the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) * 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
DE3607651A1 (en) * 1986-03-06 1987-09-10 Schering Ag COMBINATION OF AROMATASE INHIBITORS AND TESTOSTERONE-5 (ALPHA) REDUCTASE INHIBITORS
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5550134A (en) * 1995-05-10 1996-08-27 Eli Lilly And Company Methods for inhibiting bone loss

Also Published As

Publication number Publication date
AR016629A1 (en) 2001-07-25
CA2295016A1 (en) 1999-02-25
CN1263461A (en) 2000-08-16
TR199903209T2 (en) 2000-05-22
CO4960657A1 (en) 2000-09-25
WO1999008666A3 (en) 1999-04-15
PE105699A1 (en) 1999-11-25
KR20010014080A (en) 2001-02-26
JP2002511101A (en) 2002-04-09
AU9343098A (en) 1999-03-08
BR9810458A (en) 2000-09-05
EP1007010A2 (en) 2000-06-14
MA26531A1 (en) 2004-12-20
WO1999008666A2 (en) 1999-02-25
ZA987392B (en) 2000-02-17

Similar Documents

Publication Publication Date Title
GB9706089D0 (en) Pharmaceutical composition
GB9727053D0 (en) Pharmaceutical compositions
CY2569B1 (en) Pharmaceutical compositions
EP0978288A4 (en) Medicinal composition
GB9818591D0 (en) Pharmaceutical composition
IL133928A0 (en) Pharmaceutical composition containing peptichemio
GB9717444D0 (en) Pharmaceutical composition
HUP0002455A3 (en) Gastric-retained pharmaceutical composition
GB9717428D0 (en) Pharmaceutical composition
GB9723985D0 (en) Pharmaceutical compositions
GB9726735D0 (en) Pharmaceutical compositions
IL122920A (en) Castrointestinal drug composition
EP1124557A4 (en) Pharmaceutical composition
HU9700632D0 (en) Pharmaceutical compositions
GB9623962D0 (en) Pharmaceutical composition
GB9717770D0 (en) Pharmaceutical composition
GB2321190B (en) Pharmaceutical composition
GB9921495D0 (en) Pharmaceutical compositions
GB9726781D0 (en) Pharmaceutical composition
HU9701598D0 (en) Pharmaceutical composition
GB9712097D0 (en) Pharmaceutical composition
ZA981391B (en) Pharmaceutical composition
GB9717575D0 (en) Pharmaceutical composition
GB9715614D0 (en) Pharmaceutical composition
GB9702517D0 (en) Pharmaceutical composition